4D Molecular Therapeutics Inc Business Finance Contracts & Agreements
12 Contracts & Agreements
- Investor Rights Agreements (3 contracts)
- Stock Agreements (2)
- Underwriting Agreements (4)
- Warrant Agreements (3)
- Form of Pre-Funded Warrant issued in conjunction with December 2024 exchange (Filed With SEC on December 11, 2024)
- Form of Pre-Funded Warrant issued in conjunction with November 2024 exchange (Filed With SEC on November 13, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on February 9, 2024)
- Underwriting Agreement, dated as of February 6, 2024, among 4D Molecular Therapeutics, Inc. and Goldman Sachs & Co. LLC, BofA Securities, Inc., Jefferies LLC and Barclays Capital... (Filed With SEC on February 9, 2024)
- Underwriting Agreement, dated as of May 4, 2023, among 4D Molecular Therapeutics, Inc. and Goldman Sachs & Co. LLC, BofA Securities, Inc. and Evercore Group, L.L.C (Filed With SEC on May 9, 2023)
- Form of Underwriting Agreement (Filed With SEC on October 26, 2021)
- 2020 Employee Stock Purchase Plan (Filed With SEC on December 7, 2020)
- Amended and Restated Investors Rights Agreement, dated as of April 29, 2020, among the Registrant and the investors party thereto (Filed With SEC on December 7, 2020)
- Form of Common Stock Certificate (Filed With SEC on December 7, 2020)
- Form of Underwriting Agreement (Filed With SEC on December 7, 2020)
- Amended and Restated Investors Rights Agreement, dated as of April 29, 2020, among the Registrant and the investors party thereto (Filed With SEC on November 17, 2020)
- Amended and Restated Investors Rights Agreement, dated as of August 27, 2018, among the Registrant and the investors party thereto (Filed With SEC on September 30, 2019)
